Coronary artery disease screening in diabetic patients: How good is guideline adherence?

Swiss Medical Weekly

Volumn 137, Issue 13-14, 2007, Pages 199-204

  Hurni, C A ^a   Perret, S ^a   Monbaron, D ^a   Gaillard, R C ^a   Ruiz, Juan ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Cardiovascular risk factors; Coronary artery disease; Diabetes mellitus; Screening

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC PATIENT; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICIAN; PRACTICE GUIDELINE; PREVALENCE; QUESTIONNAIRE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 34248182036     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979;241(19):2035-8.
2. Haffner SM, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339(4):229-34.
3. Josie MM, Evans J.W.a.A. Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional studies. BMJ. 2002;324(7343):939.
4. Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med. 1984;311(18):1144-7.
5. Kang X, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J. 1999;138(6 Pt 1):1025-32.
6. Passa P, et al. Coronary disease and diabetes. Diabete Metab. 1995;21(6):446-51.
7. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998, Miami, Florida. American Diabetes Association. Diabetes Care, 1998. 21(9): p. 1551-9.
8. Ruiz JK, U Bulliard, C. Prévention et dépistage de la maladie coronarienne chez le patient diabétique. Bull Med Suisses. 2000;81:2596-600.
9. Gaede PH, et al. The Steno-2 study. Intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetes. Ugeskr Laeger. 2003;165(26):2658-61.
10. Gaede P, et al. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet. 1999;353(9153):617-22.
11. Wackers FJ, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care. 2004;27(8):1954-61.
12. Monbaron D, X.J., Prior J, Bischof-Delaloye A, Jaussi A, Gaillard R, Ruiz R. Effectiveness of Guidelines for the Screening of Coronary Artery Disease. Diabetes, Abstract Book of the Congress of the American Diabetes Association. 2003; p. A162.
13. Puel J, et al. Identification of myocardial ischemia in the diabetic patient. Joint ALFEDIAM and SFC recommendations. Diabetes Metab. 2004;30(3 Pt 3):3S3-18.
14. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837-53.
15. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344(8934):1383-9.
16. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360(9326):7-22.
17. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J. 2001;22(7):554-72.
18. Freeman AC, Sweeney K. Why general practitioners do not implement evidence: qualitative study. BMJ. 2001;323(7321):1100-2.
19. Diabetes care and research in Europe: the Saint Vincent declaration. Diabet Med. 1989;7:360.
20. Faglia E, et al. Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular risk: an open-label randomized pilot study. Am Heart J. 2005;149(2):e1-6.